Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2021

Feb 16, 2021

33003_dirs_2021-02-16_903cf01a-1302-41ba-b826-d1fb1eb524fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-02-12

Reporting Person: Ganot Ilan (Director, CEO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-12 Common Stock S 457 $7.6611 Disposed 3026 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 290914 Indirect
Common Stock 1199821 Direct

Footnotes

F1: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

F2: Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F3: Represents 1,139,190 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.